SCI Corporation ("CEL-SCI" or the "Company") (NYSE American: CVM), a clinical stage cancer immunotherapy company, today ...

For patients with low-risk cervical cancer, survival is similar following simple hysterectomy (SH) versus modified radical ...

Former President Joe Biden has begun his battle with what his office called an “aggressive” form of prostate cancer. “Last ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

CEL-SCI Corporation ("CEL-SCI" or the "Company") , a clinical stage cancer immunotherapy company, today announced that it intends to offer to sell shares of its common stock (and/or pre-funded ...

Former President Joe Biden has begun his battle with what his office called an "aggressive" form of prostate cancer. "Last ...

Good morning and welcome to the Replimune Fiscal Year Fourth Quarter 2025 Financial Results and Corporate Update Conference Call. Currently, all participants are in listen-only mode. This call is ...